Yüklüyor......

Liraglutide and obesity: a review of the data so far

The prevalence of obesity worldwide has nearly doubled since 1980 with current estimates of 2.1 billion in 2013. Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Des Devel Ther
Yazar: Ladenheim, Ellen E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4386791/
https://ncbi.nlm.nih.gov/pubmed/25848222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S58459
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!